AdaptHealth has named Harriss T. Currie Chief Financial Officer, effective September 9, 2026, succeeding Jason Clemens, who will remain with the company through October 1 to assist with the transition.
Currie brings extensive healthcare and public-company finance experience. He served as CFO of Luminex for more than 15 years, remaining in the position until the company’s sale to DiaSorin in 2021.
More recently, Currie served as CFO of Health Track Rx from 2025 to 2026 and Impulse Dynamics from 2022 to 2023. Between those positions, he served as President of the Regenerative Medicine division of 3D Systems from 2023 to 2025. He previously worked as an audit manager at Deloitte & Touche and holds an MBA from the McCombs School of Business at the University of Texas at Austin.
AdaptHealth provides healthcare-at-home products and services across Sleep Health, Respiratory Health, Diabetes Health and Wellness at Home. The company reaches approximately 4.5 million patients annually through approximately 670 locations in 48 states.
KEY QUOTES:
“We are delighted to welcome Harriss to AdaptHealth and look forward to the meaningful contributions we expect he will make in both the short and long term,” said Suzanne Foster, Chief Executive Officer. “We appreciate Jason’s years of service and are particularly thankful for the strong team and structure he has left for Harriss to build on.”
Suzanne Foster, Chief Executive Officer of AdaptHealth
“I am excited to join AdaptHealth and to lead the finance team through our next phase of growth. In evaluating this opportunity, I saw a strong leadership team, solid financial processes, and a business that has put strategic contracts in place to position itself for meaningful revenue and EBITDA growth. I am truly excited and appreciative of this opportunity,” said Mr. Currie.
Harriss T. Currie, Chief Financial Officer of AdaptHealth
